DOSE OF REALITY: BIG PHARMA SETS DRUG PRICES, HIKES DRUG PRICES AND BLOCKS COMPETITION TO KEEP DRUG PRICES HIGH
Sep 10, 2024
Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing… Read More
© 2024 CSRXP- All Rights Reserved
Blog Posts
CSRXP JOINS FELLOW ADVOCATES FOR LOWER DRUG PRICES TO URGE HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Sep 6, 2024
Letter Encourages Lawmakers to Advance Bipartisan Solutions to Hold Big Pharma… Read More
CSRxP Launches Seven-Figure Advertising Campaign to Hold Big Pharma Accountable for Egregious Drug Prices, Anti-Competitive Tactics and False Rhetoric
Sep 4, 2024
Campaign Will Add Support to Growing Bipartisan Momentum to Crack Down on Big… Read More
They Said It! R Street Institute Expert Explains How Big Pharma Games The Patent System to Keep “Drug Prices Artificially High”
Sep 3, 2024
New Report Emphasizes The “Pharmaceutical Industry’s Patent Gamesmanship… Read More
CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Aug 27, 2024
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY & AMGEN
Aug 26, 2024
Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1, GENE, AND CELL THERAPY PRICES PROJECTED TO INCREASE HEALTH CARE COSTS FOR EMPLOYERS
Aug 26, 2024
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
BIG PHARMA EARNINGS WATCH: GSK, PFIZER, MERCK, BRISTOL MYERS SQUIBB
Aug 7, 2024
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
BIG PHARMA EARNINGS: SANOFI, ASTRAZENECA, ROCHE AND ABBVIE
Jul 26, 2024
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS
Jul 23, 2024
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”
Jun 26, 2024
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM
Jun 25, 2024
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More